Image 1
Junel Kit
Product Images NDC 0555-9028
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 19 technical images submitted to the FDA as part of the official labeling for Junel (NDC 0555-9028). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Teva Pharmaceuticals Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Image 10
This text appears to be a set of instructions for using birth control pills. The text includes a chart labeled "STARTERS" that instructs users to place a label strip indicating the first day of their menstrual period on a day of the week. There is also a set of directions for taking the pills, including taking them left to right each week.*
Image 11
This appears to be instructions for users to take certain pills in a particular direction each week. It also mentions something about placing a label strip on a certain day depending on when the user's period begins.*
Junel 1/20 Blister Image (Image 12)
Junel 1.5/30 Blister Image (Image 13)
Jirzel 10 is a medication in the form of tablets containing norethindrone acetate and ethinyl estradiol. It is a product for women's health and is produced by Pharmaceuticals USA. No other usable information could be obtained due to distortion in the text caused by .*
Junel 1/20 Blister Image (Image 14)
NDC 0555-9026-58 is a birth control medication called Junel'Fe. It comes in a box with 6 cyclic tablet dispensers containing 28 tablets each. Each dispenser has 21 light yellow tablets and 7 brown tablets containing norethindrone acetate, ethinyl estradiol, and ferrous fumarate (which is not USP for dissolution and assay). The medication prevents pregnancy but does not protect against sexually transmitted diseases, including HIV. The product is made by Women's Health.*
Junel 1.5/30 Blister Image (Image 15)
This is a description of Junel'Fe 1, a medication that comes in a box containing 6 blister cards. Each blister card has 28 tablets, 21 of which are light yellow and the other 7 are brown. The light yellow tablets contain norethindrone acetate and ethinyl estradiol, while the brown tablets contain ferrous fumarate. The medication is taken once daily for 28 days, as directed by a physician, and the box comes with six cyclic tablet dispensers. It is important to keep the medication out of reach of children and store it between 20-25°C. The manufacturer is Teva Pharmaceuticals USA, Inc. This medication is intended for women's health purposes.*
Junel Fe 1/20 Blister Image (Image 16)
Junel Fe 1.5/30 Blister Image (Image 17)
Junel Fe 1/20 Blister Image (Image 18)
Jirzel'Fe 15m is an oral contraceptive that is designed to prevent pregnancy. However, it does not protect against sexually transmitted diseases like HIV/AIDS. It contains 28 tablets (21 pink tablets and 7 brown tablets) that consist of norethindrone acetate, ethinyl estradiol, and ferrous fumarate. The ferrous fumarate tablets are not USP for dissolution and assay. The product is packaged in blister cards with a GTIN of 00305858028582 and a JOMEN's HEALTH® label.*
Junel Fe 1.5/30 Blister Image (Image 19)
Junel'Fe 15 is a hormonal contraceptive that comes in the form of six blister cards, each containing 28 tablets. The pink tablets contain norethindrone acetate, 1.5 mg, and ethinyl estradiol, 30 mcg, while the brown tablets contain USP ferrous fumarate, 75 mg. Each tablet dispenser has 21 pink tablets and 7 brown tablets. Take one tablet daily for the entire 28 days, as directed by the physician. The packaging contains six foil pouches, each with one combination labeling piece intended for the patient, and all individuals should receive all informational pieces with each prescription. Store away from children at temperatures between 20-25°C (68-77°F).*
Image 2
Image 3
This is a table showing circulatory disease mortality rates in women per 100,000 woman years categorized by age, smoking status and oral contraceptive use. The table represents different scores for each category, ranging from 0 to 250. The age range represented in the table is from 15 to 44.*
Image 4
Image 5
This appears to be a section from the instructions for a birth control pill packet. The text provides guidance on when to start taking the pills based on the day of the week you begin your menstrual cycle, with specific instructions for "day 1 starters" who may begin their period on a day other than Sunday. There is also a diagram indicating the direction in which the pills should be taken each week.*
Image 6
This is a set of instructions for using a pill pack. It suggests placing a label strip starting from the first day of the period. Then it provides directions on how to take the pills, suggesting taking pills from left to right each week.*
Image 7
This is a set of instructions for taking birth control pills. The text instructs Day-1 starters (women who start taking the pill on a day other than Sunday) to place a strip that corresponds with the first day of their period. The pills should be taken from left to right each week. Not available if there are non-English characters that affect the meaning of the text.*
Image 8
Image 9
This is a set of instructions for taking birth control pills. The text provides information on how to start taking the pills on the first day of a menstrual cycle that does not begin on a Sunday. It includes a label strip that starts with the first day of a person's period. The instructions also indicate that the pills should be taken from left to right each week.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
